<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>CARIS LIFE SCIENCES RSS Feed | Nachrichten - www.finanzen.net</title><description>www.finanzen.net bietet Finanznachrichten zum weltweiten Börsengeschehen</description><category>Finanzen</category><link>https://www.finanzen.net</link><language>de-de</language><copyright>finanzen.net GmbH</copyright><lastBuildDate>Mon, 06 Apr 2026 16:51:31 +0200</lastBuildDate><atom:link href="https://www.finanzen.net/rss/caris%5Flife%5Fsciences%2Drss%2Dfeed" rel="self" type="application/rss+xml"/><image><url>https://images.finanzen.net/images/finanzen_net_neu.gif</url><title>CARIS LIFE SCIENCES RSS Feed | Nachrichten - www.finanzen.net</title><link>https://www.finanzen.net</link></image><item><title>CARIS Life Sciences stellte das Zahlenwerk zum vergangenen Quartal vor</title><pubDate>Sun, 01 Mar 2026 06:35:06 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/caris-life-sciences-stellte-das-zahlenwerk-zum-vergangenen-quartal-vor-15526343</link><description><![CDATA[<p><a href="https://www.finanzen.net/aktien/caris_life_sciences-aktie">CARIS Life Sciences</a> veröffentlichte am 26.02.2026 auf der all-dreimonatlichen Finanzkonferenz die Zahlen zum am 31.12.2025 abgelaufenen Jahresviertel.Der Gewinn je Aktie lag bei 0,28 USD. Im Vorjahresviertel  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/caris-life-sciences-stellte-das-zahlenwerk-zum-vergangenen-quartal-vor-15526343</guid></item><item><title>Caris Life Sciences: Hohe Nachfrage nach Dienstleistungen im Bereich der molekularen Profilerstellung ermöglicht Profitabilität im 4. Quartal - Experten bestätigen Kaufempfehlungen</title><pubDate>Fri, 27 Feb 2026 16:05:51 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/Caris-Life-Sciences-Hohe-Nachfrage-nach-Dienstleistungen-im-Bereich-der-molekularen-Profilerstellung-ermoeglicht-Profitabilitaet-im-4-Quartal-Experten-bestaetigen-Kaufempfehlungen-15523178</link><description><![CDATA[<p>Caris Life Sciences Inc.</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/Caris-Life-Sciences-Hohe-Nachfrage-nach-Dienstleistungen-im-Bereich-der-molekularen-Profilerstellung-ermoeglicht-Profitabilitaet-im-4-Quartal-Experten-bestaetigen-Kaufempfehlungen-15523178</guid></item><item><title>Ausblick: CARIS Life Sciences gewährt Anlegern Blick in die Bücher</title><pubDate>Wed, 25 Feb 2026 07:01:06 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/ausblick-caris-life-sciences-gewaehrt-anlegern-blick-in-die-buecher-15514873</link><description><![CDATA[<p><a href="https://www.finanzen.net/aktien/caris_life_sciences-aktie">CARIS Life Sciences</a> lädt am 26.02.2026 zur Finanzkonferenz und wird dort die Zahlen zum am 31.12.2025 abgelaufenen Jahresviertel vorlegen.Die Schätzungen von 6 Analysten gehen durchschnittlich von einem  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/ausblick-caris-life-sciences-gewaehrt-anlegern-blick-in-die-buecher-15514873</guid></item><item><title>Erste Schätzungen: CARIS Life Sciences stellt Zahlen zum jüngsten Quartal vor</title><pubDate>Wed, 11 Feb 2026 06:21:34 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/erste-schaetzungen-caris-life-sciences-stellt-zahlen-zum-juengsten-quartal-vor-15479587</link><description><![CDATA[<p><a href="https://www.finanzen.net/aktien/caris_life_sciences-aktie">CARIS Life Sciences</a> gibt voraussichtlich am 26.02.2026 die Zahlen für das am 31.12.2025 abgelaufene Quartal bekannt.Der Gewinn je Aktie dürfte sich laut 6 Analysten für das vergangene Quartal auf durchschnittlich  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/erste-schaetzungen-caris-life-sciences-stellt-zahlen-zum-juengsten-quartal-vor-15479587</guid></item><item><title>Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results</title><pubDate>Mon, 12 Jan 2026 14:30:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/caris-life-sciences-announces-preliminary-fourth-quarter-and-full-year-2025-results-15409131</link><description><![CDATA[<p><p class="prntac" xmlns="http://www.w3.org/1999/xhtml"><i>Full year revenue growth of approximately 94% driven by strong performance </i><i> in molecular profiling services</i><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/caris-life-sciences-announces-preliminary-fourth-quarter-and-full-year-2025-results-15409131</guid></item><item><title>Caris Life Sciences Partners with Everlywell to Launch Caris' Forthcoming MCED Assay, Caris Detect</title><pubDate>Mon, 12 Jan 2026 14:00:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/caris-life-sciences-partners-with-everlywell-to-launch-caris-forthcoming-mced-assay-caris-detect-15409040</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">IRVING, Texas, <span class="legendSpanClass"><span class="xn-chron">Jan. 12, 2026 /PRNewswire/ -- <u><a href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4593097-1&h=1264034379&u=https%3A%2F%2Fwww.carislifesciences.com%2F&a=Caris+Life+Sciences"  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/caris-life-sciences-partners-with-everlywell-to-launch-caris-forthcoming-mced-assay-caris-detect-15409040</guid></item><item><title>Caris Life Sciences to Present at the 44th Annual J.P. Morgan Healthcare Conference</title><pubDate>Mon, 05 Jan 2026 14:30:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/caris-life-sciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-15392368</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">IRVING, Texas, <span class="legendSpanClass"><span class="xn-chron">Jan. 5, 2026 /PRNewswire/ -- <a href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4588347-1&h=2666606446&u=https%3A%2F%2Fwww.carislifesciences.com%2F&a=Caris+Life+Sciences"  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/caris-life-sciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-15392368</guid></item><item><title>The Caris Precision Oncology Alliance Welcomes Providence Swedish Cancer Institute</title><pubDate>Fri, 19 Dec 2025 14:30:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/the-caris-precision-oncology-alliance-welcomes-providence-swedish-cancer-institute-15371127</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">IRVING, Texas, <span class="legendSpanClass"><span class="xn-chron">Dec. 19, 2025 /PRNewswire/ -- <a href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4584183-1&h=1636513035&u=https%3A%2F%2Fwww.carislifesciences.com%2F&a=Caris+Life+Sciences"  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/the-caris-precision-oncology-alliance-welcomes-providence-swedish-cancer-institute-15371127</guid></item><item><title>Caris Life Sciences Announces Collaboration with Genentech to Discover Novel Therapeutic Targets in Cancers with High Unmet Clinical Need</title><pubDate>Tue, 16 Dec 2025 14:30:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/caris-life-sciences-announces-collaboration-with-genentech-to-discover-novel-therapeutic-targets-in-cancers-with-high-unmet-clinical-need-15361905</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">IRVING, Texas, <span class="legendSpanClass"><span class="xn-chron">Dec. 16, 2025 /PRNewswire/ -- <u><a href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4581233-1&h=695243686&u=https%3A%2F%2Fwww.carislifesciences.com%2F&a=Caris+Life+Sciences"  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/caris-life-sciences-announces-collaboration-with-genentech-to-discover-novel-therapeutic-targets-in-cancers-with-high-unmet-clinical-need-15361905</guid></item><item><title>Caris Life Sciences to Showcase 19 Studies at the 2025 San Antonio Breast Cancer Symposium</title><pubDate>Thu, 04 Dec 2025 14:30:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/caris-life-sciences-to-showcase-19-studies-at-the-2025-san-antonio-breast-cancer-symposium-15335370</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">IRVING, Texas, <span class="legendSpanClass"><span class="xn-chron">Dec. 4, 2025 /PRNewswire/ -- <a href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4572173-1&h=3210027601&u=https%3A%2F%2Fwww.carislifesciences.com%2F&a=Caris+Life+Sciences"  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/caris-life-sciences-to-showcase-19-studies-at-the-2025-san-antonio-breast-cancer-symposium-15335370</guid></item></channel></rss>
